
Danaher Corporation
DHR · NYSE · Life Sciences Tools & Services
Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time
- Market cap
- $164 bn
- Div. yield
- 0,5%
- Year to date
- +1,8%
Ratio score
based on 9 metrics as of 16.11.2026 ·
Verdict by our methodology based on current metrics. Not an investment recommendation.
Key metrics
3 ✓ · 5 — · 1 ✕ · 1 n/a · hover over a row or tap it to see the trend
All metrics
| Metric | Value | 5-year median | Industry median |
|---|---|---|---|
| P/E TTM | 37,9 | 36,2 | 37,9 |
| Forward P/E | 25,3 | — | 29,5 |
| PEG | 4,2 | — | 3,7 |
| P/S | 6,4 | 7,2 | 6,6 |
| EV/EBITDA | 30,7 | 30,1 | 29,9 |
| P/FCF | 28,6 | — | 38,7 |
| P/B | 3,1 | 3,4 | 5,4 |
Industry median — across 11 profitable companies in “Life Sciences Tools & Services” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.
Price chart
Compare with
Choose a stock
Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.
Analysts
Ratings, 31 analysts
- Buy
- 26
- Hold
- 5
- Sell
- 0
Beat the EPS forecast in 4 of the last 4 quarters
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| Q3 2026 | 1,94 | 2,11 | Up +9,0% |
| Q2 2026 | 1,85 | 1,94 | Up +4,7% |
| Q1 2026 | 1,96 | 2,06 | Up +5,3% |
| Q4 2025 | 2,17 | 2,23 | Up +2,6% |
Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.
Financials in charts
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6,55 bn | 6,27 bn | 5,95 bn | 6,84 bn | 6,05 bn | 5,94 bn | 5,74 bn | 6,54 bn | 5,80 bn | 5,74 bn | 5,80 bn | 6,41 bn |
| EPS | 1,75 | 1,23 | 1,45 | 1,68 | 1,27 | 0,77 | 1,32 | 1,49 | 1,12 | 1,22 | 1,45 | 1,45 |
| Margin | 18,8% | 13,9% | 17,3% | 17,5% | 15,0% | 9,3% | 16,6% | 16,6% | 14,1% | 15,8% | 18,8% | 16,8% |
| FCF | 1,63 bn | 1,27 bn | 1,09 bn | 1,75 bn | 1,37 bn | 1,09 bn | 1,05 bn | 1,50 bn | 1,22 bn | 1,13 bn | 1,45 bn | 1,22 bn |
From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.
Owners
Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.
Insider trades over 12 months
Over 12 months: no purchases, sales $36,7 m.
| Name | Amount | Shares | Price |
|---|---|---|---|
| milosevich gregory m9 Nov 2026 · sale | $484 302 | 2 100 | $230,62 |
| mcgrew matthew9 Nov 2026 · sale | $4,10 m | 17 385 | $235,69 |
| bouda christopher28 Oct 2026 · sale | $763 094 | 3 253 | $234,58 |
| bouda christopher28 Oct 2026 · sale | $1,02 m | 4 345 | $234,54 |
| mcgrew matthew28 Oct 2026 · sale | $3,68 m | 15 603 | $236,09 |
| mcgrew matthew28 Oct 2026 · sale | $3,33 m | 14 151 | $235,35 |
| blair rainer21 Aug 2026 · sale | $1,70 m | 7 755 | $219,35 |
| blair rainer21 Aug 2026 · sale | $8,57 m | 39 193 | $218,73 |
| blair rainer21 Aug 2026 · sale | $2,46 m | 11 307 | $217,77 |
| spoon alan g1 May 2026 · sale | $237 207 | 1 358 | $174,67 |
| milosevich gregory m19 Feb 2026 · sale | $274 575 | 1 320 | $208,01 |
| rales mitchell p25 Nov 2025 · sale | $1,09 m | 4 726 | $231,19 |
| rales mitchell p25 Nov 2025 · sale | $8,27 m | 35 899 | $230,27 |
| list teri18 Nov 2025 · sale | $746 997 | 3 298 | $226,50 |
SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.
About the company
- Industry
- Life Sciences Tools & Services
- Exchange
- NYSE
- Country
- US
- IPO date
- 10 Dec 1969
- Website
- www.danaher.com
Company description, revenue by segment and region, and the CEO will come later.
Earnings
- Next report
- date not announced
An AI summary of the earnings call will come later.
Peers
| Company | Price | ||||
|---|---|---|---|---|---|
TMOThermo Fisher Scientific | $691,33 | 56★★★★★★★★would watch | 36,3 | +8,3% | 14,9% |
AAgilent Technologies | $172,92 | 78★★★★★★★★★would consider | 34,1 | +8,6% | 19,5% |
WATWaters Corporation | $453,42 | 29★★★★★★★would not consider | 269,0 | — | 1,8% |
IQVIQVIA | $264,73 | 72★★★★★★★★★would consider | 31,3 | +8,8% | 8,1% |
MTDMettler Toledo | $1 727,26 | 63★★★★★★★★would watch | 36,5 | +6,5% | 22,2% |
Ratio — a score by our methodology, not an investment recommendation.




